Repository logo
 
Publication

Methylotroph Infections and Chronic Granulomatous Disease

dc.contributor.authorFalcone, E. Liana
dc.contributor.authorPetts, Jennifer
dc.contributor.authorFasano, Mary Beth
dc.contributor.authorFord, Bradley
dc.contributor.authorNauseef, William
dc.contributor.authorNeves, João Farela
dc.contributor.authorSimões, Maria João
dc.contributor.authorTierce, Millard
dc.contributor.authorMorena, M. Teresa
dc.contributor.authorGreenberg, David
dc.contributor.authorZerbe, Christa
dc.contributor.authorZelazny, Adrian
dc.contributor.authorHolland, Steven
dc.date.accessioned2016-02-26T17:06:34Z
dc.date.available2016-02-26T17:06:34Z
dc.date.issued2016-03
dc.description.abstractChronic granulomatous disease (CGD) is a primary immunodeficiency caused by a defect in production of phagocyte-derived reactive oxygen species, which leads to recurrent infections with a characteristic group of pathogens not previously known to include methylotrophs. Methylotrophs are versatile environmental bacteria that can use single-carbon organic compounds as their sole source of energy; they rarely cause disease in immunocompetent persons. We have identified 12 infections with methylotrophs (5 reported here, 7 previously reported) in patients with CGD. Methylotrophs identified were Granulibacter bethesdensis (9 cases), Acidomonas methanolica (2 cases), and Methylobacterium lusitanum (1 case). Two patients in Europe died; the other 10, from North and Central America, recovered after prolonged courses of antimicrobial drug therapy and, for some, surgery. Methylotrophs are emerging as disease-causing organisms in patients with CGD. For all patients, sequencing of the 16S rRNA gene was required for correct diagnosis. Geographic origin of the methylotroph strain may affect clinical management and prognosis.pt_PT
dc.description.sponsorshipThis work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA (grant no. ZO1-AI-00646-06).pt_PT
dc.identifier.citationEmerg Infect Dis. 2016 Mar;22(3):404-9. doi: 10.3201/eid2203.151265.pt_PT
dc.identifier.doi10.3201/eid2203.151265pt_PT
dc.identifier.issn1080-6040
dc.identifier.urihttp://hdl.handle.net/10400.18/3510
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherCenters for Disease Control and Preventionpt_PT
dc.relation.publisherversionhttp://wwwnc.cdc.gov/eid/article/22/3/15-1265_articlept_PT
dc.subjectCidomonas Methanolicapt_PT
dc.subjectGranulibacter Bethesdensispt_PT
dc.subjectMethylobacterium lusitanumpt_PT
dc.subjectBacteriapt_PT
dc.subjectChronic Granulomatous Diseasept_PT
dc.subjectMethylotrophpt_PT
dc.subjectInfecções Respiratóriaspt_PT
dc.titleMethylotroph Infections and Chronic Granulomatous Diseasept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage409pt_PT
oaire.citation.startPage404pt_PT
oaire.citation.titleEmerging Infectious Diseasespt_PT
oaire.citation.volume22pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Gb CGD Patients Em Inf Dis 2016.pdf
Size:
430.65 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: